88R9626 SHH-D     By: Price H.B. No. 3152       A BILL TO BE ENTITLED   AN ACT   relating to the identification of the country of manufacture on the   label for a prescription drug or biological product.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 562.006, Occupations Code, is amended by   adding Subsection (a-1) and amending Subsection (b) to read as   follows:          (a-1)  The label on the dispensing container on a drug or   biological product dispensed by a pharmacy must indicate the   country where the drug or biological product was manufactured.          (b)  In addition to the information required by Subsections   [Subsection] (a) and (a-1), the label on the dispensing container   of a drug or biological product dispensed by a Class A or Class E   pharmacy must indicate:                (1)  the name, address, and telephone number of the   pharmacy;                (2)  the date the prescription is dispensed;                (3)  the name of the prescribing practitioner;                (4)  the name of the patient or, if the drug or   biological product was prescribed for an animal, the species of the   animal and the name of the owner;                (5)  instructions for use;                (6)  the quantity dispensed;                (7)  if the drug or biological product is dispensed in a   container other than the manufacturer's original container, the   date after which the prescription should not be used, determined   according to criteria established by board rule based on standards   in the United States Pharmacopeia-National Formulary; and                (8)  any other information required by board rule.          SECTION 2.  The Texas State Board of Pharmacy shall adopt any   rules necessary to implement Section 562.006(a-1), Occupations   Code, as added by this Act, not later than January 1, 2024.          SECTION 3.  The change in law made by this Act applies only   to a drug or biological product dispensed on or after March 1, 2024.     A drug or biological product dispensed before March 1, 2024, is   governed by the law in effect immediately before the effective date   of this Act, and the former law is continued in effect for that   purpose.          SECTION 4.  This Act takes effect September 1, 2023.